0

By Tennille Luker

In QLD, VIC

Posted June 21, 2022

An early feasibility study of the safety of an endovascular Motor Neuroprosthesis (MNP) in participants with severe upper limb dysfunction

READ MORE

0

By Tennille Luker

In ACT, NSW, NT, QLD, SA, TAS, VIC, WA

Posted June 16, 2022

The Wellbeing Neuro Course: A Randomised Controlled Trial of an Online Treatment Program for Adults with Multiple Sclerosis

READ MORE

0

By Tennille Luker

In NSW, QLD, VIC

Posted June 7, 2022

A Study To Evaluate The Efficacy And Safety Of Fenebrutinib Compared With Ocrelizumab In Adult Participants With Primary Progressive Multiple Sclerosis (FENtrepid)

READ MORE

0

By Tennille Luker

In QLD

Posted June 1, 2022

Reducing the frequency of Autoimmune adverse events in the treatment of Multiple sclerosis with alemtuzumab using B-celL dEpletion (RAMBLE): a phase II, randomised, placebo-controlled clinical trial

READ MORE